Literature DB >> 2122429

The need for new therapeutic approaches in visceral leishmaniasis during HIV infection.

A Lafeuillade, R Quilichini, C Dhiver, C Mary, J A Gastaut.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2122429      PMCID： PMC2426897          DOI： 10.1136/pgmj.66.779.789

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  6 in total

1.  Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma.

Authors:  R Badaro; E Falcoff; F S Badaro; E M Carvalho; D Pedral-Sampaio; A Barral; J S Carvalho; M Barral-Netto; M Brandely; L Silva
Journal:  N Engl J Med       Date:  1990-01-04       Impact factor: 91.245

2.  Allopurinol for treatment of visceral leishmaniasis in patients with AIDS.

Authors:  P Dellamonica; E Bernard; Y Le Fichoux; S Politano; M Carles; J Durand; V Mondain
Journal:  J Infect Dis       Date:  1989-11       Impact factor: 5.226

3.  Asymptomatic leishmaniasis in the acquired immunodeficiency syndrome (AIDS)

Authors:  M J Condom; B Clotet; G Sirera; F Milla; M Foz
Journal:  Ann Intern Med       Date:  1989-11-01       Impact factor: 25.391

4.  Visceral leishmaniasis (kala azar) in a patient with AIDS.

Authors:  D Smith; B Gazzard; R P Lindley; A Darwish; C Reed; A D Bryceson; D A Evans
Journal:  AIDS       Date:  1989-01       Impact factor: 4.177

5.  Immunochemotherapy for intracellular Leishmania donovani infection: gamma interferon plus pentavalent antimony.

Authors:  H W Murray; J D Berman; S D Wright
Journal:  J Infect Dis       Date:  1988-05       Impact factor: 5.226

6.  Visceral leishmaniasis in patients infected with human immunodeficiency virus (HIV).

Authors:  J Berenguer; S Moreno; E Cercenado; J C Bernaldo de Quirós; A García de la Fuente; E Bouza
Journal:  Ann Intern Med       Date:  1989-07-15       Impact factor: 25.391
  6 in total
  1 in total

1.  Itraconazole as maintenance therapy for visceral leishmaniasis in HIV-infected patients.

Authors:  G Angarano; P Maggi; S L Coppola; R L Cavaliere
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-05       Impact factor: 3.267
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.